Dynamic new medical device company, Medovate Ltd, based in Cambridge, United Kingdom, will be exhibiting at Arab Health for the first time in 2020, where they will be showcasing their revolutionary new technology for regional anaesthesia.
Medovate develops and manufactures innovative new medical technologies arising from within the National Health Service (NHS) in the United Kingdom. The product range covers exciting new technologies for Regional Anaesthesia and Critical Care.
Giving Anaesthetists Control
SAFIRA (Safer Injection for Regional Anaesthesia) is a ground-breaking solution to help prevent patient nerve damage during nerve block procedures. SAFIRA facilitates a single operator procedure by allowing a single operator, an anaesthetist, to conduct the whole regional block at safe pressures.
Current regional anaesthesia procedures require two operators: an anaesthetist who holds an ultrasound scanner and uses this to guide the needle tip placement and a second operator to inject the anaesthetic solution at a required pressure. It has been reported that anaesthetic solutions are often injected at high pressure, causing damage to nerve fascicles and in some cases serious nerve damage.
SAFIRA incorporates an engineered safety solution to help control the injection pressure threshold, and allows the anaesthetist to control the entire procedure, improving patient safety.
Be amongst the first to see revolutionary new technology
SAFIRA will take centre stage on the Medovate stand at Arab Health 2020. Medovate are exhibiting as part of the Association of British Healthcare Industries (ABHI) pavilion on stand number #H2.G50R.
Visitors to Arab Health 2020 will be amongst the first to see this recently launched innovative new technology, developed with clinicians working in the UK National Health Service (NHS).
Medovate will be actively seeking commercial partners at Arab Health 2020 as part of growing a distribution network for their new technology across the region to make available to medical professionals to help improve outcomes for patients.
Make sure you make a visit to the Medovate stand part of your itinerary for Arab Health 2020 so you do not miss the chance to find out about this exciting new technology and how it can help clinicians, as well as potential distribution opportunities.
Quality assured innovation
Medovate is British Standards ISO 13485:2016 certified. All devices in its growing portfolio are manufactured in compliance with the most stringent quality and regulatory standards. In 2019 the company was named 'Most Innovative Medical Device Development Company' in Eastern England.
Contact: enquiries@medovate.co.uk
Read more: www.medovate.co.uk
Follow on Twitter: @Medovate
